当前位置:首页 - 行情中心 - 诺泰生物(688076) - 财务分析

诺泰生物

(688076)

  

流通市值:118.75亿  总市值:118.75亿
流通股本:3.15亿   总股本:3.15亿

诺泰生物(688076)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润1.48亿元,每股收益0.69元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益283602.21万元,未分配利润87502.49万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产543909.83万元,负债260307.62万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入565,595,756.611,624,801,884.871,252,252,784.74831,498,746.79
营业总成本375,513,297.491,132,858,689.8832,401,194.11552,758,685.92
营业利润177,502,119.95448,218,444.01389,429,394.38258,910,004
利润总额177,344,968.48438,504,152.57385,239,321.13256,962,652.74
净利润147,874,049.26399,818,448.38350,696,470.09231,765,163.69
其他综合收益----
综合收益总额147,874,049.26399,818,448.38350,696,470.09231,765,163.69
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计1,998,059,721.242,005,525,493.251,831,306,768.961,721,845,364.28
非流动资产合计3,441,038,610.433,072,489,569.292,611,302,755.362,293,616,083.85
资产总计5,439,098,331.675,078,015,062.544,442,609,524.324,015,461,448.13
流动负债合计1,881,617,515.581,752,710,190.281,436,691,049.961,253,632,989.36
非流动负债合计721,458,732.04642,988,240.74366,876,858.48341,260,168.79
负债合计2,603,076,247.622,395,698,431.021,803,567,908.441,594,893,158.15
归属于母公司股东权益合计2,818,423,652.942,660,367,001.732,616,678,543.032,394,349,891.83
股东权益合计2,836,022,084.052,682,316,631.522,639,041,615.882,420,568,289.98
负债和股东权益合计5,439,098,331.675,078,015,062.544,442,609,524.324,015,461,448.13
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计584,845,735.171,581,467,362.961,137,418,208.44745,700,341.76
经营活动现金流出小计439,469,082.521,181,351,285.08870,113,910.56547,267,698.95
经营活动产生的现金流量净额145,376,652.65400,116,077.88267,304,297.88198,432,642.81
投资活动现金流入小计470,883,472.031,508,356,131.91,242,482,406.59776,484,943.6
投资活动现金流出小计655,312,151.962,901,548,305.322,082,745,774.411,328,154,212.17
投资活动产生的现金流量净额-184,428,679.93-1,393,192,173.42-840,263,367.82-551,669,268.57
筹资活动现金流入小计274,792,998.631,821,170,908.381,098,313,384.08672,928,687.5
筹资活动现金流出小计165,903,437.411,021,416,311.26660,675,193.59459,732,990.61
筹资活动产生的现金流量净额108,889,561.22799,754,597.12437,638,190.49213,195,696.89
汇率变动对现金及现金等价物的影响567,791.368,344,284.541,407,296.873,273,509.77
现金及现金等价物净增加额70,405,325.3-184,977,213.88-133,913,582.58-136,767,419.1
期末现金及现金等价物余额562,960,844.23492,555,518.93543,619,150.23540,765,313.71
最新报告期:2025-05-09
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
东海证券杜永宏2.533.414.402025-05-09
中泰证券崔少煜,祝嘉琦2.543.444.672025-05-07
华福证券陈铁林2.453.273.992025-05-06
中信建投王云鹏,袁清慧,贺菊颖2.443.153.852025-04-30
民生证券杨涛,王班2.443.174.082025-04-25
TOP↑